Strength
30 mg/1
Manufacturer
AvPAKNDC
50268064215
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
PAROXETINE HYDROCHLORIDE HEMIHYDRATEApproval Type
Generic (ANDA)
FDA Application
ANDA078406On Market Since
3/11/2016
Pharmacological Classes
Price Statistics
The NADAC for PAROXETINE HCL 30 MG TABLET has been published 450 times since Nov 15, 2017, and over the history we have for it it has declined 18.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0947 per EA |
|---|---|
| All-time high | $0.1374 (Aug 10, 2022) |
| All-time low | $0.0735 (Nov 20, 2024) |
| 52-week high | $0.1098 |
| 52-week low | $0.0946 |
| Median price | $0.1098 |
| Average price | $0.1096 |
| Largest weekly change | +27.2% (Nov 22, 2023) |
| Weeks tracked | 450 |
| Tracking since | Nov 15, 2017 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of PAROXETINE HCL 30 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PAROXETINE HCL 30 MG TABLET, manufactured by AvPAK, is $0.0947 per EA (NDC 50268064215), effective Jun 24, 2026.
How has the price of PAROXETINE HCL 30 MG TABLET changed over time?
Over the history we have for it, the NADAC for PAROXETINE HCL 30 MG TABLET has declined 18.5%. It has been tracked across 450 weekly CMS publications since Nov 15, 2017.
What are the highest and lowest recorded NADAC prices for PAROXETINE HCL 30 MG TABLET?
Since Nov 15, 2017, the NADAC for PAROXETINE HCL 30 MG TABLET has ranged from a low of $0.0735 (Nov 20, 2024) to a high of $0.1374 (Aug 10, 2022), with a median of $0.1098 per EA.
Are there cheaper alternatives to PAROXETINE HCL 30 MG TABLET?
3 NADAC-published products share the same active ingredient, strength, and dosage form as PAROXETINE HCL 30 MG TABLET, but none are currently priced below it.
Who manufactures PAROXETINE HCL 30 MG TABLET?
PAROXETINE HCL 30 MG TABLET (NDC 50268064215) is labeled by AvPAK, and CMS classifies it as a generic product.
Related Drugs
Same classification